Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Extended treatment of Cushing's disease with pasireotide: results from a 2-year, Phase II study.

Extended treatment of Cushing's disease with pasireotide: results from a 2-year, Phase II study. Pituitary. 2014 Aug; 17(4):320-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.